{"DataElement":{"publicId":"5040674","version":"1","preferredName":"Chronic Graft Versus Host Disease Oral Cavity Involvement NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"Information related to the NIH Consensus Response Criteria for cGVHD severity of oral cavity involvement.","longName":"5040556v1.0:5040673v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"5040556","version":"1","preferredName":"Chronic Graft Versus Host Disease Oral Cavity Involvement","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation._The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue._To have a connection by participation or association or use; sharing in an activity or process.","longName":"5040554v1.0:2192548v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"5040554","version":"1","preferredName":"Chronic Graft Versus Host Disease Oral Cavity","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.:The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.","longName":"C4981:C12421","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Oral Cavity","conceptCode":"C12421","definition":"The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-46AF-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192548","version":"1","preferredName":"Involvement","preferredDefinition":"To have a connection by participation or association or use; sharing in an activity or process.","longName":"C25548","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Involvement","conceptCode":"C25548","definition":"To have a connection by participation or association or use; sharing in an activity or process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9F4C3B9-9218-0989-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-29","modifiedBy":"DATA_LOADER","dateModified":"2005-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2351E2EE-46BD-B747-E050-BB89AD430EFA","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5040673","version":"1","preferredName":"Oral Cavity NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue._A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999)._Used of the degree of something undesirable e.g. pain or weather; also, strictness._A number or range of numeric values measuring performance, function, quality, or ability","longName":"5040673v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Score 3","valueDescription":"Severe symptoms with disease signs on examination with major limitation of oral intake","ValueMeaning":{"publicId":"2666676","version":"1","preferredName":"Severe symptoms with disease signs on examination with major limitation of oral intake","longName":"2666676","preferredDefinition":"Severe symptoms with disease signs on examination with major limitation of oral intake","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35F36190-6D6C-4859-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2353FFBF-36B5-EAC9-E050-BB89AD434F78","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Score 2","valueDescription":"Moderate symptoms with disease signs with partial limitation of oral intake","ValueMeaning":{"publicId":"2666675","version":"1","preferredName":"Moderate symptoms with disease signs with partial limitation of oral intake","longName":"2666675","preferredDefinition":"Moderate symptoms with disease signs with partial limitation of oral intake","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35F1DA73-CDF4-089A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2353FFBF-36C9-EAC9-E050-BB89AD434F78","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Score 1","valueDescription":"Mild symptoms with disease signs but not limiting oral intake significantly","ValueMeaning":{"publicId":"2666674","version":"1","preferredName":"Mild symptoms with disease signs but not limiting oral intake significantly","longName":"2666674","preferredDefinition":"Mild symptoms with disease signs but not limiting oral intake significantly","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"35F32DDE-708A-2B4B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-23","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-23","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2353FFBF-36DD-EAC9-E050-BB89AD434F78","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"},{"value":"Score 0","valueDescription":"No symptoms","ValueMeaning":{"publicId":"3476036","version":"1","preferredName":"No symptoms","longName":"3476036","preferredDefinition":"No symptoms","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1FA8D5E-27E8-5806-E040-BB89AD43560B","latestVersionIndicator":"Yes","beginDate":"2012-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-06-08","modifiedBy":"KUMMEROA","dateModified":"2022-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2353FFBF-36F1-EAC9-E050-BB89AD434F78","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"ONEDATA","dateModified":"2015-10-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5042819","version":"1","preferredName":"Oral Cavity NIH Consensus Response Criteria for cGVHD Severity Score","preferredDefinition":"The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.:A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252¿266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).:Severity; used of the degree of something undesirable e.g. pain or weather.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C12421:C103138:C25676:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Cavity","conceptCode":"C12421","definition":"The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"NIH Consensus Response Criteria for Chronic GVHD","conceptCode":"C103138","definition":"A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH Chronic Graft-versus-Host Disease Consensus Response Criteria Working Group. The criteria were established in 2005 (Biol Blood Marrow Transplant, 12 (2006), pp. 252-266) and revised in 2014 (Biol Blood Marrow Transplant, 21 (2015), pp. 984-999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"23CCF37B-99A3-FBD3-E050-BB89AD432528","latestVersionIndicator":"Yes","beginDate":"2015-11-05","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-05","modifiedBy":"ONEDATA","dateModified":"2015-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2353FFBF-3695-EAC9-E050-BB89AD434F78","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"NYCHM","dateModified":"2017-01-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"HPST_CGHD_cgvhd_mouth_NIH_scor","type":"NMDP_FN","context":"NHLBI"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"What is the NIH Consensus Res","type":"Preferred Question Text","description":"What is the NIH Consensus Response Criteria for cGVHD severity of oral cavity involvement?","url":null,"context":"NHLBI"},{"name":"Mouth score","type":"Alternate Question Text","description":"Mouth score","url":null,"context":"NHLBI"},{"name":"Mouth score","type":"Application Standard Question Text","description":"Mouth score","url":null,"context":"NHLBI"},{"name":"NIH mouth score","type":"Alternate Question Text","description":"NIH mouth score","url":null,"context":"NHLBI"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Mouth:","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2353FFBF-3703-EAC9-E050-BB89AD434F78","latestVersionIndicator":"Yes","beginDate":"2015-10-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-10-30","modifiedBy":"MAESKEB","dateModified":"2022-03-31","changeDescription":"AQT added for 2100r7. 04/23/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}